ATE549351T1 - Chimärer peptidantagonist für gpcr135 oder gpcr142 - Google Patents

Chimärer peptidantagonist für gpcr135 oder gpcr142

Info

Publication number
ATE549351T1
ATE549351T1 AT08724770T AT08724770T ATE549351T1 AT E549351 T1 ATE549351 T1 AT E549351T1 AT 08724770 T AT08724770 T AT 08724770T AT 08724770 T AT08724770 T AT 08724770T AT E549351 T1 ATE549351 T1 AT E549351T1
Authority
AT
Austria
Prior art keywords
gpcr135
gpcr142
chimeric peptide
peptide antagonist
gpcr1
Prior art date
Application number
AT08724770T
Other languages
English (en)
Inventor
Chester Kuei
Changlu Liu
Cindy Pudiak
Jonathan Shelton
Steven Sutton
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE549351T1 publication Critical patent/ATE549351T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08724770T 2007-01-30 2008-01-23 Chimärer peptidantagonist für gpcr135 oder gpcr142 ATE549351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89869307P 2007-01-30 2007-01-30
PCT/US2008/000917 WO2008094437A2 (en) 2007-01-30 2008-01-23 Chimeric peptide antagonist for gpcr135 or gpcr142

Publications (1)

Publication Number Publication Date
ATE549351T1 true ATE549351T1 (de) 2012-03-15

Family

ID=39674681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08724770T ATE549351T1 (de) 2007-01-30 2008-01-23 Chimärer peptidantagonist für gpcr135 oder gpcr142

Country Status (4)

Country Link
US (1) US8299028B2 (de)
EP (1) EP2129359B1 (de)
AT (1) ATE549351T1 (de)
WO (1) WO2008094437A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9056922B2 (en) 2007-10-30 2015-06-16 Howard Florey Institute Of Experimental Physiology And Medicine Chimeric relaxin polypeptides comprising an A and B chain derived from different relaxin family peptides
CA2813802C (en) 2010-09-08 2020-06-09 Howard Florey Institute Of Experimental Physiology And Medicine Single chain relaxin polypeptides
WO2012031328A1 (en) * 2010-09-08 2012-03-15 Howard Florey Institute Of Experimental Physiology And Medicine Treatments for substance abuse and addiction

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068862A1 (en) * 2000-03-10 2001-09-20 Zymogenetics, Inc. Insulin homolog polypeptide zins4
AU4880901A (en) * 2000-04-21 2001-11-07 Takeda Chemical Industries Ltd Novel insulin/igf/relaxin family polypeptides and dnas thereof
AU2001276837A1 (en) 2000-06-23 2002-01-08 Tularik, Inc. Human and mouse g-protein couipled receptors
AUPR814401A0 (en) * 2001-10-08 2001-11-01 Howard Florey Institute Of Experimental Physiology And Medicine Human 3 relaxin
US20060188956A1 (en) 2003-03-04 2006-08-24 Jingcai Chen Relaxin3-gpcr135 complexes and their production and use
AU2003903124A0 (en) 2003-06-20 2003-07-10 Mark Del Borgo Analogues of heteromeric proteins
AU2004255200A1 (en) 2003-06-30 2005-01-20 Merck & Co., Inc. 17-acetamido-4-azasteroid derivatives as androgen receptor modulators
CA2534739A1 (en) 2003-08-07 2005-02-17 Janssen Pharmaceutica N.V. Complexes of gpcr142 and relaxin3 or insl5, and their production and use
ATE555126T1 (de) 2004-08-25 2012-05-15 Janssen Pharmaceutica Nv Relaxin-chimere polypeptide und deren herstellung und anwendung
WO2007117400A2 (en) 2006-03-31 2007-10-18 Janssen Pharmaceutica N.V. Benzoimidazol-2-yl pyridines as modulators of the histamine h4 receptor

Also Published As

Publication number Publication date
EP2129359A2 (de) 2009-12-09
EP2129359A4 (de) 2011-05-18
US20100145007A1 (en) 2010-06-10
EP2129359B1 (de) 2012-03-14
US8299028B2 (en) 2012-10-30
WO2008094437A3 (en) 2008-11-06
WO2008094437A2 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
NO20090047L (no) Anti-DLL4-antistoffer og fremgangsmater for anvendelse av disse
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
DK2035447T3 (da) Polypeptid
TNSN07264A1 (en) Organic compounds
NO20083485L (no) Templatfikserte peptidhermere med antimikrobeaktivitet
MX382321B (es) Nuevo polipéptido con afinidad por pd-l1.
ATE485359T1 (de) Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche
MX2007002675A (es) Antagonistas anti-beta7 humanizados y usos para los mismos.
CU23872B1 (es) Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina
MX2007006830A (es) Porciones de la familia del polipeptido pancreatico, polipeptidos y metodos que comprenden las mismas.
BRPI0510674A (pt) variantes fc otimizadas
MX2008013859A (es) Nano-aditivo para operaciones de cementado de pozos de hidrocarburos.
CR11504A (es) Deteccion mejorada de la expresion de mage-a
EA200601029A1 (ru) Способ очистки фсг
PL1987357T3 (pl) Polipeptydy rozpoznawane przez przeciwciała anty-Trichinella oraz ich zastosowanie
CL2007002389A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento y/o profilaxis de obesidad, hirsutismo, hipertricosis y verrugas viricas.
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
EA200701528A1 (ru) Новые нутрицевтические композиции
WO2007106792A3 (en) Methods for treating sarcopenia with a growth hormone secretagogue
ATE549351T1 (de) Chimärer peptidantagonist für gpcr135 oder gpcr142
AP2415A (en) Bacteriocin Inducer peptides.
ATE539762T1 (de) Aminosäureersatz für peptidkonstruktionen
DE602007006493D1 (de) Peptide mit proliferationshemmender wirkung
DE502005005283D1 (de) Flexible fertigungslinie zum bearbeiten von gleichartigen werkstücken
DE602007009367D1 (de) Yl)-n-methylbenzylamin